Recursos para la atención de pacientes con cáncer de mama en México

Abstract

Multicenter studies on breast cancer require inter-institutional collaboration, resources and specialized personnel. In Mexico, many institutions provide these services, but their information is not accessible; to mitigate it, the Mexican Society of Oncology formed the Mexican Cooperative Research Groups in Oncology. Objective: To describe the infrastructure, personnel and activities of hospitals with care of patients with breast cancer in Mexico. Methods: A survey was conducted to 30 breast cancer specialists about resources and services of their institutions. Results: 13 (43.3%) specialists answered the survey, 38.5% of Seguro Popular, 23.1% of Instituto Mexicano del Seguro Social, and 38.4% of other institutions, with a median of 300 (50-950) new cases per year. All the institutions have oncological surgery, breast radiology, palliative care, pathology, nutrition and multidisciplinary sessions. All have ultrasound with breast transducer, 92.3% digital mammography, and 53.8% tomosynthesis and/or magnetic resonance. They do sentinel lymph node detection with dye (92.3%) or radionuclide (61.5%). Tamoxifen, aromatase inhibitors and trastuzumab are available in 92.3%, and other target therapies in < 40%. Genetic signatures are done in 21.3% and 61.5% analysis of hereditary cancer. Conclusions: The institutional capacity to participate in multicenter studies is heterogeneous; the few resources in several institutions limit their inclusion to studies of breast cancer.

Geographical variability of mammograms for breast cancer in Jalisco, Mexico, 2013-2015

“…However, the National Health System does not have sufficient resources to carry out population screening 5 and, if required, to provide clinical care for BC in women 11 , in addition to the fact that the available infrastructure is underused, which causes low coverage in several States of the country 5,12 . Although it is true that identification of risk factors at the individual level, such as age or family history, allows defining population groups susceptible to screening 7 , it is also important for the places (neighborhoods, municipalities, health regions) where early detection programs should be focused to be identified, which implies not only improving the distribution of health services aimed at this purpose and geographically bringing screening closer to the groups at higher risk (women aged ≥ 40 years) 13 , but also substantially increasing efficiency of the programs 13 .…”

Variabilidad geográfica de mastografías de cáncer de mama en Jalisco, México, 2013-2015

“…However, the National Health System does not have sufficient resources to carry out population screening 5 and, if required, to provide clinical care for BC in women 11 , in addition to the fact that the available infrastructure is underused, which causes low coverage in several States of the country 5,12 . Although it is true that identification of risk factors at the individual level, such as age or family history, allows defining population groups susceptible to screening 7 , it is also important for the places (neighborhoods, municipalities, health regions) where early detection programs should be focused to be identified, which implies not only improving the distribution of health services aimed at this purpose and geographically bringing screening closer to the groups at higher risk (women aged ≥ 40 years) 13 , but also substantially increasing efficiency of the programs 13 .…”